For over 20 years, PERQUE and ELISA/ACT Biotechnologies (EAB) have been your partners in Integrative Healthcare.
The Well Guard Program supports you as you lead your patients down the path to wellness through:
Alkalinization Targeted Supplementation & Delayed Allergy Testing
This week’s Clinical Pearl focuses on Delayed Allergy Testing with the LRA by ELISA/ACT test from EAB.
Today, at least one out of every six Americans, or 40 million people in the United States, suffer from one or more of the autoimmune and immune dysfunction diseases. In response, chronically ill Americans spend over $300 billion per year directly for autoimmune syndrome treatments that often do not reduce their suffering or improve their health. Dr. Jaffe developed the patented LRA by ELISA/ACT tests and treatment plan in 1984, enabling thousands of physicians to quickly and precisely determine the hidden causes of many chronic conditions and help their patients find sustained relief.
Practitioners Rely on LRA by ELISA/ACT tests because they are:
Specific and Accurate:
EAB’s LRA test utilizes an ex-vivo assay that analyzes the lymphocytes’ response to foreign invaders under controlled laboratory conditions as they react in the bloodstream. This technique provides highly specific and accurate information.
A recently published article in Natural Medicine Journal provides conclusive evidence that the reliability and reproducibility of particle or cell size testing (such as the testing performed by ALCAT) does not have a high degree of accuracy.
Tests all 3 delayed allergy pathways, much more than IgG tests or ELISA IgG tests. Over 450 test items, the most of any lab.
LRA by ELISA/ACT tests distinguish between reactive and protective antibodies. Only LRA by ELISA/ACT looks at reactive, harmful antibodies that provoke symptoms not protective, beneficial, neutralizing antibodies. This distinction is clinically important and can only be made by a functional lymphocyte response assay.
For over 20 years, patients have been enjoying dramatic improvements in quality of life as a result of treatment protocols developed and clinically validated by EAB.
Read about successful patient outcomes in difficult clinical cases through use of the LRA by ELISA/ACT tests and treatment plans.
To learn more about LRA by ELISA/ACT tests visit www.ELISAACT.com or call 1-800-553-5472 or email EAB Client Services